A longitudinal model for disease progression was developed and applied to multiple sclerosis

Journal of Clinical Epidemiology

Volumn 68, Issue 11, 2015, Pages 1355-1365

  Lawton, Michael ^a   Tilling, Kate ^a   Robertson, Neil ^b   Tremlett, Helen ^c   Zhu, Feng ^c   Harding, Katharine ^b   Oger, Joel ^c   Ben Shlomo, Yoav ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Fractional polynomials; Multilevel model; Multiple sclerosis; Observational cohorts; Prognosis; Repeated measures model

Indexed keywords

ADULT; ARTICLE; CANADA; CHRONIC DISEASE; CLINICAL OBSERVATION; COHORT ANALYSIS; DATA BASE; DISABILITY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; MULTILEVEL ANALYSIS; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RELAPSE; UNITED KINGDOM; STATISTICAL MODEL;

ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; MULTIPLE SCLEROSIS;

EID: 84945436943     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2015.05.003     Document Type: Article

References (46)

1. E.W. Steyerberg, K.G. Moons, D.A. van der Windt, J.A. Hayden, P. Perel, S. Schroter, and et al. Prognosis research strategy (PROGRESS) 3: prognostic model research PLoS Med 10 2013 e1001381
2. H. Liu, L.G. Miller, R.D. Hays, C.E. Golin, T. Wu, N.S. Wenger, and et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors J Acquir Immune Defic Syndr 41 2006 315 322
3. C. Proust-Lima, and J.M. Taylor Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach Biostatistics 10 2009 535 549
4. K. Tilling, J.A. Sterne, and C.D. Wolfe Multilevel growth curve models with covariate effects: application to recovery after stroke Stat Med 20 2001 685 704
5. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 46 1996 907 911
6. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
7. A. Scalfari, A. Neuhaus, M. Daumer, G.C. Ebers, and P.A. Muraro Age and disability accumulation in multiple sclerosis Neurology 77 2011 1246 1252
8. H. Tremlett, Y. Zhao, P. Rieckmann, and M. Hutchinson New perspectives in the natural history of multiple sclerosis Neurology 74 2010 2004 2015
9. S. Vukusic, and C. Confavreux Natural history of multiple sclerosis: risk factors and prognostic indicators Curr Opin Neurol 20 2007 269 274
10. A. Achiron Predicting the course of relapsing-remitting MS using longitudinal disability curves J Neurol 251 Suppl 5 2004 v65 v68
11. A. Achiron, Y. Barak, and Z. Rotstein Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis Mult Scler 9 2003 486 491
12. S.A. Gauthier, M. Mandel, C.R. Guttmann, B.I. Glanz, S.J. Khoury, R.A. Betensky, and et al. Predicting short-term disability in multiple sclerosis Neurology 68 2007 2059 2065
13. J. Palace, T. Bregenzer, H. Tremlett, J. Oger, F. Zhu, M. Boggild, and et al. UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model BMJ open 4 2014 e004073
14. H. Goldstein Multilevel statistical models Wiley series in probability and statistics 4th ed. 2011 Wiley Chichester, West Sussex 358 xxi
15. K. Tilling, J.A. Sterne, A.G. Rudd, T.A. Glass, R.J. Wityk, and C.D. Wolfe A new method for predicting recovery after stroke Stroke 32 2001 2867 2873
16. J.L. Bosch, K. Tilling, A.M. Bohnen, and J.L. Donovan Establishing normal reference ranges for PSA change with age in a population-based study: the Krimpen study Prostate 66 2006 335 343
17. K. Tilling, H. Garmo, C. Metcalfe, L. Holmberg, F.C. Hamdy, D.E. Neal, and et al. Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts Eur Urol 57 2010 446 452
18. C. Di Serio, and C. Lamina Investigating determinants of multiple sclerosis in longitunal studies: a Bayesian approach J Probab Stat 2009 2009
19. M. Boggild, J. Palace, P. Barton, Y. Ben-Shlomo, T. Bregenzer, C. Dobson, and et al. Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator BMJ 339 2009 b4677
20. R.J. Swingler, and D.A. Compston The prevalence of multiple sclerosis in south east Wales J Neurol Neurosurg Psychiatry 51 1988 1520 1524
21. A. Hennessey, N.P. Robertson, R. Swingler, and D.A. Compston Urinary, faecal and sexual dysfunction in patients with multiple sclerosis J Neurol 246 1999 1027 1032
22. A. Hennessy, R.J. Swingler, and D.A. Compston The incidence and mortality of multiple sclerosis in south east Wales J Neurol Neurosurg Psychiatry 52 1989 1085 1089
23. C. Hirst, G. Ingram, T. Pickersgill, R. Swingler, D.A. Compston, and N.P. Robertson Increasing prevalence and incidence of multiple sclerosis in South East Wales J Neurol Neurosurg Psychiatry 80 2009 386 391
24. H. Tremlett, D. Paty, and V. Devonshire Disability progression in multiple sclerosis is slower than previously reported Neurology 66 2006 172 177
25. C. Evans, E. Kingwell, F. Zhu, J. Oger, Y. Zhao, and H. Tremlett Hospital admissions and MS: temporal trends and patient characteristics Am J Manag Care 18 2012 735 742
26. M. Koch, E. Kingwell, P. Rieckmann, and H. Tremlett The natural history of secondary progressive multiple sclerosis J Neurol Neurosurg Psychiatry 81 2010 1039 1043
27. A. Shirani, Y. Zhao, M.E. Karim, C. Evans, E. Kingwell, M.L. van der Kop, and et al. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis JAMA 308 2012 247 256
28. H. Tremlett, Y. Zhao, J. Joseph, V. Devonshire, and U.C. Neurologists Relapses in multiple sclerosis are age- and time-dependent J Neurol Neurosurg Psychiatry 79 2008 1368 1374
29. H. Tremlett, F. Zhu, J. Petkau, J. Oger, and Y. Zhao Natural, innate improvements in multiple sclerosis disability J Mult Scler 18 10 2012 1412 1421
30. A. Shirani, Y. Zhao, E. Kingwell, P. Rieckmann, and H. Tremlett Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009) Mult Scler 18 2012 442 450
31. P. Royston, and D.G. Altman Regression using fractional polynomials of continuous covariates - parsimonious parametric modeling Appl Statistics-Journal R Stat Soc Ser C 43 3 1994 429 467
32. L.D. Howe, K. Tilling, A. Matijasevich, E.S. Petherick, A.C. Santos, L. Fairley, and et al. Linear spline multilevel models for summarising childhood growth trajectories: a guide to their application using examples from five birth cohorts Stat Methods Med Res 2013 (in press)
33. D.E. Goodkin, D. Cookfair, K. Wende, D. Bourdette, P. Pullicino, B. Scherokman, and et al. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke expanded disability status scale (EDSS). Multiple sclerosis collaborative research group Neurology 42 1992 859 863
34. S. Hughes, T. Spelman, M. Trojano, A. Lugaresi, G. Izquierdo, F. Grand'maison, and et al. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry J Neurol Neurosurg Psychiatry 83 2012 305 310
35. J. Rasbash, C. Charlton, K. Jones, and R. Pillinger Manual supplement to MLwiN v2.26 2012 Centre for Multilevel Modelling, University of Bristol UK
36. C.L. Hirst, G. Ingram, T.P. Pickersgill, and N.P. Robertson Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome J Mult Scler 18 8 2012 1152 1158
37. StataCorp Stata Statistical Software: Release 11 2009 StataCorp LP College Station, TX
38. G. Leckie, and C. Charlton runmlwin: Stata module for fitting multilevel models in the MLwiN software package 2011 Centre for Multilevel Modelling, University of Bristol UK
39. H.Q. Pan, and H. Goldstein Multi-level models for longitudinal growth norms Stat Med 16 1997 2665 2678
40. P. Royston, G. Ambler, and W. Sauerbrei The use of fractional polynomials to model continuous risk variables in epidemiology Int J Epidemiol 28 1999 964 974
41. W. Sauerbrei, and P. Royston Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials J R Stat Soc Ser A (Statistics Society) 162 1 1999 71 94
42. J. Long, and J. Ryoo Using fractional polynomials to model non-linear trends in longitudinal data Br J Math Stat Psychol 63 2010 177 203
43. X. Wen, K. Kleinman, M.W. Gillman, S.L. Rifas-Shiman, and E.M. Taveras Childhood body mass index trajectories: modeling, characterizing, pairwise correlations and socio-demographic predictors of trajectory characteristics BMC Med Res Methodol 12 2012 38
44. J.M. Taylor, and N. Law Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts? Stat Med 17 1998 2381 2394
45. T.M. Palmer, C.M. Macdonald-Wallis, D.A. Lawlor, and K. Tilling Estimating adjusted associations between random effects from multilevel models: The reffadjust package Stata Journal 14 1 2014 119 140
46. J.M. Taylor, Y. Park, D.P. Ankerst, C. Proust-Lima, S. Williams, L. Kestin, and et al. Real-time individual predictions of prostate cancer recurrence using joint models Biometrics 69 2013 206 213